AbbVie and Xilio Therapeutics, Inc., a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced a collaboration...
BlossomHill Therapeutics, Inc., a clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, announced...
Adicet Bio, a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, announced the appointment...
BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, announced the appointment of Olav Hellebø as...
Alpha-9 Oncology Inc, a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, announced an oversubscribed $175 million Series...
